Search the Newsreel

Wall Street Analysts Think Crane NXT (CXT) Could Surge 25.63%: Read This Before Placing a Bet

Crane NXT (CXT) closed the last trading session at $53.33, gaining 4.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target …

Huanxi Media Reshapes Governance Team with New Joint Company Secretaries

Xinjiang Xinxin Mining Sets August Board Meeting to Approve Interim Results

Yunnan Jinxun Flags Sharp Interim Profit Rise on Stronger Copper Prices

NXP Semiconductors N.V. $NXPI Holdings Boosted by NewEdge Advisors LLC

NewEdge Advisors LLC significantly increased its stake in NXP Semiconductors N.V. by 235.9% in the first quarter, bringing its total holdings to 41,652 shares valued at approximately $8.2 million. Institutional investors collectively own 90.54% of the company's stock, and analysts maintain a "Moderate Buy" …

Manx Financial boosts share capital with scrip dividend and bonus issue

Manx Financial Group (MFX) to Issue Over 2 Million Shares via Scrip Dividend and Bonus Issue, AIM Admission Set for 20 August 2026

Nextdoor Holdings Ord Shs Class A (NXDR) Earnings Forecast: Future EPS & Revenue Growth Estimates

RGNX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of REGENXBIO Inc. to Contact the Firm Today!

Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against REGENXBIO Inc. (NASDAQ:RGNX) on behalf of investors who purchased securities between February 9, 2022, and January 27, 2026. The lawsuit alleges that REGENXBIO made materially false and misleading statements regarding the development …

Regenxbio Inc (RGNX) Earnings Forecast: Future EPS & Revenue Growth Estimates

NXP Semiconductors (NASDAQ:NXPI) Downgraded to Buy Rating by Wall Street Zen

Wall Street Zen has downgraded NXP Semiconductors (NASDAQ:NXPI) from a "strong buy" to a "buy" rating, despite the broader analyst consensus remaining a "Moderate Buy" with an average target price of $305.43. NXP recently reported strong quarterly earnings of $3.61 per share, exceeding estimates, …

IperionX Ltd (30Z.MU) Analyst Insights, Price Targets & Recommendations

This page provides analyst insights, price targets, and recommendations for IperionX Ltd (30Z.MU). It also displays current stock performance, market data, and links to various financial tools and information. The content appears to be a stub or a placeholder page from Yahoo Finance.

REGENXBIO (RGNX) Stock Drops Despite Profit Surprise And Longer Cash Runway

REGENXBIO (RGNX) experienced a nearly 5% stock drop despite reporting a surprise profit of US$0.43 EPS and US$108 million in revenue for Q2 2026, swinging from a significant loss. The company also extended its cash runway into Q4 2027 due to funding from AbbVie …

NAMI Surges Then Retraces As Traders Gauge Volatility

Jinxin Technology Holding Company (NASDAQ: NAMI) experienced a significant surge of 38.14% due to optimism surrounding a recent technology breakthrough, followed by a sharp retracement, indicating high volatility. Analysts highlight NAMI as a distressed micro-cap in the media/interactive space with low valuation metrics but …

NAMI Jumps On Volatility As Traders Watch Key Levels

Jinxin Technology Holding Company (NASDAQ: NAMI) stock has experienced extreme volatility, jumping over 38% recently, driven by positive sentiment and speculative trading. Despite showing poor historical profitability with significant accumulated losses, the stock exhibits solid liquidity, making it a high-risk trading option. Traders are …

Bank of America Securities Reaffirms Their Buy Rating on RegenXBio (RGNX)

argenx SE (ARGX) stock price, news, quote and history

This Yahoo Finance page provides comprehensive information on argenx SE (ARGX), a commercial-stage biopharmaceutical company focused on autoimmune diseases. It details the company's stock performance, key financial metrics, product pipeline, strategic partnerships, and analyst ratings. The article highlights argenx's main product, VYVGART, and several …

Sei Investments Co. Buys 28,571 Shares of BlueLinx Holdings Inc. $BXC

Sei Investments Co. increased its stake in BlueLinx Holdings Inc. by 92.1% in the first quarter, purchasing an additional 28,571 shares to bring its total holdings to 59,592 shares, valued at $3.23 million. Other institutional investors also adjusted their positions in BlueLinx, with 90.83% …

Crane NXT (CXT) Reaffirms Guidance And Dividend, Is The Stock Still Undervalued?

Crane NXT (CXT) has reaffirmed its full-year sales growth guidance of 15% to 17% and declared a quarterly dividend of US$0.18 per share after reporting strong second-quarter 2026 results. Despite a mixed long-term share price performance, Simply Wall St. analysis suggests the stock is …

Quanex Building Products Corp (NX) Earnings Forecast: Future EPS & Revenue Growth Estimates

Quanex Building Products Corp (NX) has an earnings forecast score of 9.00, ranking 2nd in the Homebuilding & Construction Supplies industry. Analysts have set an average price target of $29.50, with a consensus of "Strong Buy" based on 2 analysts. The company's expected revenue …

BlueLinx (NYSE:BXC) Upgraded by Wall Street Zen to Buy Rating

Pulmonx (LUNG) Q2 2026 Earnings Call Transcript

Pulmonx (LUNG) reported its Q2 2026 earnings, highlighting a 34% reduction in net loss and a 39% decrease in adjusted EBITDA loss, driven by cost alignment initiatives. The company reiterated its full-year revenue guidance of $90 million to $92 million and expects to return …

NXP Semiconductors N.V. (NASDAQ:NXPI) Receives Average Rating of "Moderate Buy" from Brokerages

NXP Semiconductors N.V. (NASDAQ:NXPI) has received a "Moderate Buy" consensus rating from 26 analysts, with an average 12-month price target of $305.43. The company recently surpassed earnings and revenue estimates, reporting $3.61 EPS and $3.50 billion in revenue, and pays a quarterly dividend of …

CNX Resources Corp (CNX) Stock News Today

This article from TradingKey provides current stock information for CNX Resources Corp (CNX), an oil and gas company. It displays the latest stock price, market capitalization, P/E ratio, and notes that more news and updates on earnings and analyst ratings are forthcoming.

Crane NXT Q2 Earnings Call Highlights

Key Points Interested in Crane NXT, Co.? Here are five stocks we like better. Strong second-quarter results: Crane NXT sales rose 22% year over year to $493 million, while adjusted EPS increased 13% to $1.10 and adjusted EBITDA margin expanded to approximately 23%. Full-year …

argenx SE (ARGX) Aktuelle Aktien-News

CNX5752902 Bond Profile — Key Metrics

This article provides key metrics for the CNX5752902 bond issued by CNX Resources Corporation. It details the bond's coupon rate, issue and maturity dates, outstanding amount, and face value. Additionally, it offers a brief company description for CNX Resources Corp., highlighting its natural gas …

NXP Semiconductors N.V. stock underperforms Friday when compared to competitors despite daily gains

Shares of NXP Semiconductors N.V. (NXPI) rose 3.42% on Friday, closing at $239.71. Despite these daily gains, the stock underperformed compared to its competitors. The S&P 500 Index (SPX) and Dow Jones Industrial Average (DJIA) also saw increases on what was an overall positive …

REGENXBIO Inc. Stock 12‑Month Price Target Raised to $26.17, Implies 149% Upside

Analysts have raised REGENXBIO Inc.'s average 12-month price target from $26 to $26.17, indicating a potential upside of approximately 149% from its August 5 closing price. The consensus rating for RGNX remains a "Buy" among 12 analysts, with 11 recommending a Buy and 1 …

Barclays downgrades Regenxbio stock rating on regulatory uncertainty

Barclays downgraded Regenxbio Inc. (NASDAQ:RGNX) to Equalweight from Overweight, setting a price target of $12.00 due to regulatory uncertainty surrounding its Duchenne muscular dystrophy (DMD) program and competitive landscape for wet age-related macular degeneration (wet AMD). Despite a recent 16% stock increase, the firm …

Earnings Update: Here's Why Analysts Just Lifted Their Nextdoor Holdings, Inc. (NYSE:NXDR) Price Target To US$3.21

Nextdoor Holdings, Inc. (NYSE:NXDR) recently reported better-than-expected second-quarter results, with revenues exceeding estimates and smaller statutory losses. Following these positive results, analysts have significantly upgraded their revenue forecasts and reduced loss per share predictions for 2026, leading to a 22% increase in the price …

Lanxess AG (LNXSF) (Q2 2026) Earnings Call Highlights: Operational Turning Point Drives ...

This article first appeared on GuruFocus. EBITDA: Strong sequential increase in Q2 2026, in line with company expectations. Cash Flow: Improved in Q2 2026, driven by tight net working capital management, especially on the inventory side. Net Financial Debt: Consistently reduced over the last …

How Investors May Respond To NXP (NXPI) Balancing Auto Exposure, AI Ambitions, And Aggressive Buybacks

NXP Semiconductors N.V. recently reported strong Q2 2026 sales and net income, along with Q3 guidance and the completion of a share buyback program. Despite these positive results, concerns arise from NXP's heavy automotive market exposure, particularly in China, and its relatively modest involvement …

Projeções de Resultados: NXP Semiconductors NV (NXPI) — LPA e Crescimento de Receita

Jinxin Fertility Sets August Board Meeting to Approve Interim Results

Jinxin Technology (NAMI): Wu Capital and Xinyi Cai report 10.79% beneficial stake

Wu Capital Limited and Xinyi Cai have jointly reported a beneficial ownership of 10.79% in Jinxin Technology Holding Co (NAMI) through a Schedule 13G/A filing. This stake, amounting to 153,552,600 ordinary shares, is held directly by Wu Capital Limited, with Xinyi Cai owning 100% …